Kiromic BioPharma, Inc. (KRBPQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0360
0.00 (0.00%)
Jun 27, 2025, 9:30 AM EDT
Kiromic BioPharma Market Cap
Kiromic BioPharma has a market cap or net worth of $56.24 thousand as of June 30, 2025. Its market cap has decreased by -97.14% in one year.
Market Cap
56.24K
Enterprise Value
13.49M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.04
Market Cap Chart
Since October 16, 2020, Kiromic BioPharma's market cap has decreased from 84.33M to 56.24K, a decrease of -99.93%. That is a compound annual growth rate of -78.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2025 | 56.24K | -96.00% |
| Dec 31, 2024 | 1.41M | 28.38% |
| Dec 29, 2023 | 1.09M | -66.79% |
| Dec 30, 2022 | 3.30M | -86.04% |
| Dec 31, 2021 | 23.62M | -61.97% |
| Dec 31, 2020 | 62.11M | -26.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.60B |
| Elite Pharmaceuticals | 779.84M |
| Veradigm | 755.74M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| American Oncology Network | 414.48M |
| Glass House Brands | 405.91M |
| CytoDyn | 375.37M |